These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37917177)

  • 41. Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.
    Kemp K; Kemp M; Kharazmi A; Ismail A; Kurtzhals JA; Hviid L; Theander TG
    Clin Exp Immunol; 1999 Jun; 116(3):500-4. PubMed ID: 10361241
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Jamal F; Singh MK; Hansa J; Pushpanjali ; Ahmad G; Dikhit MR; Umar MS; Bimal S; Das P; Mujeeb AA; Singh SK; Zubair S; Owais M
    Front Immunol; 2020; 11():817. PubMed ID: 32582140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.
    Nico D; Claser C; Borja-Cabrera GP; Travassos LR; Palatnik M; Soares IS; Rodrigues MM; Palatnik-de-Sousa CB
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e866. PubMed ID: 21085470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
    Shao TY; Hsu LH; Chien CH; Chiang BL
    Sci Rep; 2016 Sep; 6():32415. PubMed ID: 27581189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
    Bhowmick S; Ravindran R; Ali N
    Vaccine; 2007 Aug; 25(35):6544-56. PubMed ID: 17655984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis.
    Khare P; Jaiswal AK; Tripathi CD; Joshi S; Sundar S; Dube A
    Parasitol Res; 2014 Mar; 113(3):851-62. PubMed ID: 24370734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrophage-mediated gliadin degradation and concomitant IL-27 production drive IL-10- and IFN-γ-secreting Tr1-like-cell differentiation in a murine model for gluten tolerance.
    van Leeuwen MA; Costes LMM; van Berkel LA; Simons-Oosterhuis Y; du Pré MF; Kozijn AE; Raatgeep HC; Lindenbergh-Kortleve DJ; van Rooijen N; Koning F; Samsom JN
    Mucosal Immunol; 2017 May; 10(3):635-649. PubMed ID: 27579860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
    Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
    Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.
    Gruarin P; Maglie S; De Simone M; Häringer B; Vasco C; Ranzani V; Bosotti R; Noddings JS; Larghi P; Facciotti F; Sarnicola ML; Martinovic M; Crosti M; Moro M; Rossi RL; Bernardo ME; Caprioli F; Locatelli F; Rossetti G; Abrignani S; Pagani M; Geginat J
    Eur J Immunol; 2019 Jan; 49(1):96-111. PubMed ID: 30431161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells.
    Ding Q; Lu L; Wang B; Zhou Y; Jiang Y; Zhou X; Xin L; Jiao Z; Chou KY
    J Immunol; 2006 Sep; 177(6):3606-14. PubMed ID: 16951320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
    Kaye PM; Curry AJ; Blackwell JM
    J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.
    Kushawaha PK; Gupta R; Tripathi CD; Sundar S; Dube A
    PLoS One; 2012; 7(4):e35670. PubMed ID: 22539989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.
    Varikuti S; Natarajan G; Oghumu S; Sperling RH; Moretti E; Stock J; Papenfuss TL; Satoskar AR
    Cell Immunol; 2016 Nov; 309():61-68. PubMed ID: 27614845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis.
    Suman SS; Amit A; Singh KP; Gupta P; Equbal A; Kumari A; Topno RK; Ravidas V; Pandey K; Bimal S; Das P; Ali V
    Cytokine; 2018 Aug; 108():1-8. PubMed ID: 29554571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1.
    Chowdhury BP; Das S; Majumder S; Halder K; Ghosh S; Biswas S; Bandyopadhyay S; Majumdar S
    Pathog Dis; 2015 Nov; 73(8):ftv063. PubMed ID: 26297915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-21 Expression Determines the Early Vaccine Immunity Induced by
    Gannavaram S; Bhattacharya P; Siddiqui A; Ismail N; Madhavan S; Nakhasi HL
    Front Immunol; 2019; 10():2273. PubMed ID: 31608064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct evidence for role of anti-saliva antibodies against salivary gland homogenate of P. argentipes in modulation of protective Th1-immune response against Leishmania donovani.
    Pushpanjali ; Thakur AK; Purkait B; Jamal F; Singh MK; Ahmed G; Bimal S; Kumar V; Singh SK; Keshri S; Das P; Narayan S
    Cytokine; 2016 Oct; 86():79-85. PubMed ID: 27484246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leishmania antigens activated CD4
    Singh A; Mahapatra B; Banerjee A; Singh S; Singh S; Dubey VK; Das P; Singh RK
    Cytokine; 2024 Jan; 173():156435. PubMed ID: 37950929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.
    Melby PC; Yang YZ; Cheng J; Zhao W
    Infect Immun; 1998 Jan; 66(1):18-27. PubMed ID: 9423834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.